AI can help uncover new treatments for Parkinsons disease?

The aging population and the intrinsic elusive nature of neuro-degenerative diseases makes finding a cur an elusive task. While big pharma increasingly gives up to find a cure for ALS, Parkinson, Alzheimer a group of artificial intelligence startups are rising to the challenge. Dr. Victor Hanson-Smith from Verge Genomics discusses an Artificial Intelligence pioneering approach to cure ALS and Parkinson in a conversation with Paolo Messina

Subscribe to Conversations in Artificial Intelligence






More about Victor Hanson-Smith



More about the interviewer: Paolo Messina


Become an AI manager with our courses:








Check out our document Intelligence service at
#Parkisons #Tumors #Interview
Download my free AI productivity app

artificial intelligence applications in healthcare,drug discovery and development process,drug discovery lecture,drug discovery,drug discovery startup,neurodegenerative disease,neurodegenerative disease pharmacology,neurodegenerative,verge genomics,verge genomics alice zhang,verge genomics interview,Victor Hanson-Smith,Machine learning,ai,ai applications in business,conversations in artificial intelligence,interview with Paolo Messina,Paolo Messina,parkins,tumor,